kabutan

3-D Matrix,Ltd.(7777) Summary

7777
TSE Growth
3-D Matrix,Ltd.
371
JPY
+53
(+16.67%)
Dec 12, 3:30 pm JST
2.38
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
364
Dec 12, 11:58 pm JST
Summary Chart Historical News Financial Result
PER
148.4
PBR
12.8
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:21 am
375 JPY 2.40 USD
Previous Close Dec 11
318 JPY 2.03 USD
High Dec 12, 9:25 am
397 JPY 2.55 USD
Low Dec 12, 1:01 pm
348 JPY 2.23 USD
Volume
25,258,400
Trading Value
9.44B JPY 0.06B USD
VWAP
373.66 JPY 2.4 USD
Minimum Trading Value
37,100 JPY 238 USD
Market Cap
0.04T JPY 0.29B USD
Number of Trades
10,728
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
1,238
1-Year High Sep 16, 2025
16,543
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 13,773,900
Nov 28, 2025 2,000 11,774,300 5887.15
Nov 21, 2025 0 12,300,000
Nov 14, 2025 0 12,473,800
Nov 7, 2025 0 13,046,800
Company Profile
3-D Matrix, Ltd. is a bioventure company that develops medical products by applying peptide technology. The company operates both domestically and internationally.
Sector
Precision Instruments
3-D Matrix, Ltd. conducts research and development, manufacturing, and sales of medical devices and pharmaceuticals based on self-assembling peptide technology, for which it has obtained an exclusive license from MIT. The company's main development pipeline includes absorbable local hemostatic agents for surgical applications, mucosal lifting agents, post-bleeding prevention materials, adhesion prevention materials, wound healing materials for tissue regeneration, alveolar bone reconstruction materials, and drug delivery systems (DDS) for nucleic acid therapeutics. 3-D Matrix has established direct sales systems in the United States, Japan, and Australia, while also conducting sales through partner companies in some regions.